The effects of HIV medications on the quality of life of older adults in New York City

Health Economics (United Kingdom)

Volumn 21, Issue 8, 2012, Pages 967-976

  Brent, Robert J ^a  

^a FORDHAM UNIVERSITY   (United States)

Author keywords

antiretroviral medications; depression; elderly with HIV AIDS; quality of life

Indexed keywords

ANTIRETROVIRUS AGENT;

AGE; AGING; ANTIVIRAL THERAPY; ARTICLE; DEPRESSION; DISEASE SEVERITY; DRUG EFFECT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; STIGMA; UNITED STATES; VIRUS TRANSMISSION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AGE FACTORS; AGED; ANTI-RETROVIRAL AGENTS; DEPRESSION; FEMALE; HEALTH STATUS; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; NEW YORK CITY; QUALITY OF LIFE;

EID: 84863463735     PISSN: 10579230     EISSN: 10991050     Source Type: Journal    
DOI: 10.1002/hec.1774     Document Type: Article

References (18)

1. The All Party Parliamentary Group on AIDS, APPG. 2009. The Treatment Timebomb: report of the Inquiry of the All Party Parliamentary Group on AIDS into long-term access to HIV medicines in the developing world, July 2009. (Available from: http://www.publications.parliament.uk/pa/cm200910/cmselect/ cmintdev/49/49i.pdf) [18 March 2010].
2. Applebaum A, Brennan M,. 2009. Mental health and depression. In Older Adults with HIV: An In-Depth Examination of an Emerging Population, Brennan M, Karpiak SE, Shippy RA, Cantor MH, (eds.). Nova Science Publishers: New York; 27-34.
3. Baltagli BH,. 1989. A Hausman specification test in a simultaneous equation model. Econometric Theory 5: 465-467.
4. Brent RJ, Brennan M, Karpiak S,. 2010. Economic evaluations of HIV prevention in rich countries and the need to focus on the aging of the HIV-positive population. Current Opinion in HIV and AIDS 5: 255-260.
5. Brent RJ,. 2011. An implicit price of a DALY for use in a cost-benefit analysis of ARVs. Applied Economics 43: 1413-1421.
6. CDC [Center for Disease Control and Prevention]. 2007. Cases of HIV/AIDS, HIV incidence, and cases of AIDS. (Available from: http://www.cdc.gov/hiv/ topics/surveillance/resources/reports/2007report/pdf/2007SurveillanceReport.pdf) [22 April 2010].
7. Freedberg KA, Scharfstein JA, Seage III GR, et al,. 1998. The cost-effectiveness of preventing AIDS-Related Opportunistic infections. Journal of the American Medical Association 279: 130-136.
8. Freedberg KA, Losina E, Weinstein MC, et al,. 2001. The cost-effectiveness of combination antiretroviral therapy for HIV disease. The New England Journal of Medicine 344: 824-831. (Pubitemid 32222162)
9. Heckman TG, Kochman A, Sikkema KJ,. 2002. Depressive symptoms in older adults living with HIV disease: application of the chronic illness quality of life model. Journal of Mental Health and Aging 8: 267-279. (Pubitemid 36532245)
10. Honiden S, Sandaram V, Nease RF, et al,. 2006. The effect of diagnosis with HIV infection on health-related quality of life. Quality of Life Research 15: 69-82. (Pubitemid 43102473)
11. Johnson CJ, Heckman TG, Hansen NB, et al,. 2009. Adherence to antiretroviral medication in older adults living with HIV/AIDS: a comparison of alternative models. AIDS Care 21: 541-51.
12. Karpiak SE, Brennan M,. 2009. The emerging population of older adults with HIV and introduction to the ROAH research study. In Older Adults with HIV: An In-Depth Examination of an Emerging Population, Brennan M, Karpiak SE, Shippy RA, Cantor MH, (eds.). Nova Science Publishers: New York; 1-12.
13. Low-Beer S, Chan K, Yip B, et al,. 2000. Depressive symptoms decline among persons on HIV protease inhibitors. Journal of Acquired Immune Deficiency Syndromes 23: 295-301. (Pubitemid 30327031)
14. Radloff LS,. 1977. The CES-D scale: a self report depression scale for research in the general population. Applied Psychological Measurement 1: 385-401.
15. Tengs TO, Lin TH,. 2002. A meta-analysis of utility estimates for HIV/AIDS. Medical Decision Making 22: 475-481. (Pubitemid 35334817)
16. Torrance GW,. 1976. Social preferences for health states: an empirical evaluation of three measurement techniques. Socioeconomic Planning Science 10: 128-136.
17. Walensky RP, Paltiel AD, Losina E, et al,. 2006. The survival benefits of AIDS treatment in the United States. The Journal of Infectious Diseases 194: 11-19.
18. Wu AW, Rubin HR, Mathews WC, et al,. 1991. A health status questionnaire using 30 items from the Medical Outcomes Study. Preliminary validation in persons with early infection. Medical Care 29: 786-798.